Literature DB >> 1531063

The immune response to hepatitis B vaccine in humans: inheritance patterns in families.

M S Kruskall1, C A Alper, Z Awdeh, E J Yunis, D Marcus-Bagley.   

Abstract

We have recently shown that the human antibody response to the hepatitis B virus surface antigen (HBsAg) vaccine is major histocompatibility complex (MHC) associated. In studies of nonresponders to the vaccine, we found an increased incidence of individuals homozygous for human histocompatibility leukocyte antigen (HLA) proteins associated with the extended (conserved) haplotype [HLA-B8,SC01,DR3]. In later prospective vaccination trials, we showed that none of five individuals homozygous for this haplotype developed more than 1,300 radioimmunoassay (RIA) units of antibody (mean, 467 RIA units), while all heterozygotes made at least 2,500 RIA units (mean antibody level, 15,608 units). Our results suggested that [HLA-B8,SC01,DR3] lacks an immune response gene for HBsAg, and that response is inherited in a dominant fashion. To provide further evidence for this hypothesis, we have now analyzed the results of HBsAg immunization in families. 43 members of 10 families were immunized with the hepatitis B vaccine, including seven families where at least one member bore the haplotype [HLA-B8,SC01,DR3], and three families where one member had already received, but failed to respond to, the vaccine. In two of these three families, the presence of [HLA-B8,SC01,DR3] was subsequently found. Of nine MHC-identical sibling pairs in the study, both members of eight pairs had similar antibody responses (five nonresponder and three responder pairs). In all families with such sibling pairs, including the discordant pair, rank-ordering members by antibody level demonstrated that no relative's value came between the sibling pair values. Furthermore, of nine [HLA-B8,SC01,DR3]-haplotype-homozygous individuals, six were nonresponders, and two others had only low-normal responses. [HLA-B8,SC01,DR3]-heterozygous family members always had higher levels of antibody than their homozygous relatives. Linkage analysis of nonresponse to HLA haplotypes revealed a maximum likelihood LOD (logarithm of the odds) score of 6.3 at a recombination fraction of 0.1. The MHC association with lack of antibody response to HBsAg was not seen with tetanus immunization, where 1 of 20 HBsAg responders and 1 of 21 poor or nonresponders had tetanus titers of less than 1:512; both tetanus nonresponders were [HLA-B8,SC01,DR3] heterozygotes. Our results indicate that: (a) response to the HBsAg vaccine is MHC linked, and inherited in a dominant fashion; (b) an abnormal or missing immune response (Ir) gene for HBsAg is a characteristic of most examples of the extended haplotype [HLA-B8,SC01,DR3]; and (c) other haplotypes also have abnormal or missing Ir genes for HBsAg.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1531063      PMCID: PMC2119114          DOI: 10.1084/jem.175.2.495

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  35 in total

1.  HLA-B8,DR3 phenotype and lymphocyte responses to phytohaemagglutinin.

Authors:  M A Modica; G Cammarata; C Caruso
Journal:  J Immunogenet       Date:  1990 Feb-Apr

2.  Genetic prediction of nonresponse to hepatitis B vaccine.

Authors:  C A Alper; M S Kruskall; D Marcus-Bagley; D E Craven; A J Katz; S J Brink; J L Dienstag; Z Awdeh; E J Yunis
Journal:  N Engl J Med       Date:  1989-09-14       Impact factor: 91.245

3.  HLA-Bw54-DR4-DRw53-DQw4 haplotype controls nonresponsiveness to hepatitis-B surface antigen via CD8-positive suppressor T cells.

Authors:  H Watanabe; M Okumura; K Hirayama; T Sasazuki
Journal:  Tissue Antigens       Date:  1990-08

4.  Persistence of anti-HBs among health care personnel immunized with hepatitis B vaccine.

Authors:  M T Pasko; T R Beam
Journal:  Am J Public Health       Date:  1990-05       Impact factor: 9.308

5.  Studies of intestinal lymphoid tissue. XIV--HLA status, mucosal morphology, permeability and epithelial lymphocyte populations in first degree relatives of patients with coeliac disease.

Authors:  M N Marsh; I Bjarnason; J Shaw; A Ellis; R Baker; T J Peters
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

6.  Immune suppression gene on HLA-Bw54-DR4-DRw53 haplotype controls nonresponsiveness in humans to hepatitis B surface antigen via CD8+ suppressor T cells.

Authors:  H Watanabe; S Matsushita; N Kamikawaji; K Hirayama; M Okumura; T Sasazuki
Journal:  Hum Immunol       Date:  1988-05       Impact factor: 2.850

7.  Small intestinal biopsies and HLA types in dermatitis herpetiformis patients with granular and linear IgA skin deposits.

Authors:  T J Lawley; W Strober; H Yaoita; S I Katz
Journal:  J Invest Dermatol       Date:  1980-01       Impact factor: 8.551

8.  Defective Fc-receptor functions associated with the HLA-B8/DRw3 haplotype: studies in patients with dermatitis herpetiformis and normal subjects.

Authors:  T J Lawley; R P Hall; A S Fauci; S I Katz; M I Hamburger; M M Frank
Journal:  N Engl J Med       Date:  1981-01-22       Impact factor: 91.245

9.  A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. A report from the Multicenter AIDS Cohort Study.

Authors:  R A Kaslow; R Duquesnoy; M VanRaden; L Kingsley; M Marrari; H Friedman; S Su; A J Saah; R Detels; J Phair
Journal:  Lancet       Date:  1990-04-21       Impact factor: 79.321

10.  Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population.

Authors:  R B Wainwright; B J McMahon; L R Bulkow; D B Hall; M A Fitzgerald; A P Harpster; S C Hadler; A P Lanier; W L Heyward
Journal:  JAMA       Date:  1989-04-28       Impact factor: 56.272

View more
  29 in total

1.  HLA tissue types in nonresponders to hepatitis B vaccine.

Authors:  B Durupinar; G Okten
Journal:  Indian J Pediatr       Date:  1996 May-Jun       Impact factor: 1.967

2.  Genetic determinants of immune-response to a polysaccharide vaccine for typhoid.

Authors:  Partha P Majumder; Herman F Staats; Neeta Sarkar-Roy; Binuja Varma; Trina Ghosh; Sujit Maiti; K Narayanasamy; Carol C Whisnant; James L Stephenson; Diane K Wagener
Journal:  Hugo J       Date:  2010-03-11

3.  Non-responsiveness to hepatitis B surface antigen vaccines is not caused by defective antigen presentation or a lack of B7 co-stimulation.

Authors:  I Desombere; T Cao; Y Gijbels; G Leroux-Roels
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

Review 4.  Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Richard B Kennedy; Iana H Haralambieva; Robert M Jacobson
Journal:  OMICS       Date:  2011-07-06

5.  Impaired hepatitis B vaccine responses during chronic hepatitis C infection: involvement of the PD-1 pathway in regulating CD4(+) T cell responses.

Authors:  Jonathan P Moorman; Chun L Zhang; Lei Ni; Cheng J Ma; Ying Zhang; Xiao Y Wu; Penny Thayer; Tareq M Islam; Thomas Borthwick; Zhi Q Yao
Journal:  Vaccine       Date:  2011-03-03       Impact factor: 3.641

6.  Genomics of immune response to typhoid and cholera vaccines.

Authors:  Partha P Majumder
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-19       Impact factor: 6.237

7.  Hepatitis B virus vaccine immune response and mortality in dialysis patients: a meta-analysis.

Authors:  Suwasin Udomkarnjananun; Kullaya Takkavatakarn; Kearkiat Praditpornsilpa; Claudia Nader; Somchai Eiam-Ong; Bertrand L Jaber; Paweena Susantitaphong
Journal:  J Nephrol       Date:  2019-11-07       Impact factor: 3.902

8.  Genomic correlates of variability in immune response to an oral cholera vaccine.

Authors:  Partha P Majumder; Neeta Sarkar-Roy; Herman Staats; T Ramamurthy; Sujit Maiti; Goutam Chowdhury; Carol C Whisnant; K Narayanasamy; Diane K Wagener
Journal:  Eur J Hum Genet       Date:  2012-12-19       Impact factor: 4.246

9.  Response to hepatitis B vaccination in patients with celiac disease.

Authors:  Emel Ahishali; Gungor Boztas; Filiz Akyuz; Duygu Ibrisim; Sule Poturoglu; Binnur Pinarbasi; Sadakat Ozdil; Zeynel Mungan
Journal:  Dig Dis Sci       Date:  2007-12-20       Impact factor: 3.199

10.  Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen.

Authors:  Isabelle Desombere; Annick Willems; Yvonne Gijbels; Geert Leroux-Roels
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.